Variable | AE-IIP total population (n = 68) | AE-IPF subpopulation (n = 28) | ||
---|---|---|---|---|
 | HR (95% CI) | p value | HR (95% CI) | p value |
Clinical variables | ||||
 Age | 1.059 (1.007–1.113) | 0.025* | 1.045 (0.952–1.147) | 0.357 |
 FVC %pred | 0.985 (0.961–1.008) | 0.195 | 1.023 (0.991–1.057) | 0.164 |
 Time from diagnosis to admission, months (median IQR) | 1.010 (0.999–1.020) | 0.066 | 1.013 (0.991–1.034) | 0.255 |
 Treatment duration from admission, days (median IQR) | 0.961 (0.915–1.009) | 0.110 | 0.940 (0.856–1.031) | 0.187 |
 Female gender | 2.420 (1.166–5.025) | 0.018* | NA | NA |
 Ex smoker | 0.631 (0.312–1.279) | 0.202 | 1.120 (0.248–5.054) | 0.883 |
 Current smoker | 0.000 (5× e− 191 - 963× e177) | 0.957 | NA | NA |
Biomarkers | ||||
 BGM | 1.047 (0.759–1.442) | 0.783 | 0.966 (0.562–1.662) | 0.901 |
 C1M | 1.277 (0.946–1.714) | 0.108 | 1.449 (0.911–2.316) | 0.116 |
 C3M | 1.010 (0.722–1.412) | 0.955 | 0.878 (0.486–1.585) | 0.665 |
 C4M | 1.214 (0.879–1.675) | 0.237 | 1.115 (0.681–1.831) | 0.663 |
 C6M | 1.042 (0.774–1.406) | 0.785 | 1.160 (0.702–1.915) | 0.564 |
 CRPM | 0.959 (0.707–1.304) | 0.792 | 0.939 (0.538–1.638) | 0.824 |
 ELM7 | 1.101 (0.798–1.518) | 0.559 | 0.954 (0.559–1.628) | 0.862 |
 VCANM | 0.636 (0.432–0.937) | 0.022* | 0.828 (0.446–1.538) | 0.551 |